hsa-mir-1250: Hsa-mir-1250 is a microRNA that has been studied in relation to overall survival and its role in various diseases [PMC8797878]. It is one of the top six miRNAs selected to construct a regulatory network and has been found to be associated with poor prognosis [PMC8797878]. Hsa-mir-1250 has also been identified as one of the miRNAs that bind to hsa_circ_0065898 [PMC8797878]. It is targeted by hsa-miR-520h, hsa-miR-874, hsa-miR-634, and hsa-miR-520g [PMC8483823]. Hsa-mir-1250 originated after the human-chimp split and seems to play a role in oligodendrocyte proliferation and differentiation [PMC3544654][PMC5123339]. In breast cancer luminal A, hsa-mir-1250 is one of the 11 identified miRNAs that could be key modulators of various pathways [PMC5123339]. Hsa-mir-1250 has also been described in the white matter tracts of the human brain [PMC5123339]. In metastatic cancer, at least 36 metastamiRs, including hsa-mir-1250, have been found to be altered [PMC4491873]. References: [PMC8797878] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797878/ [PMC8483823] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483823/ [PMC3544654] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544654/ [PM5123339] - https://www.ncbi.nlm.nih.gov/pmc/articles/PM5123339/ [PM4491873] - https://www.ncbi.nlm.nih.gov/pmc/articles/PM4491873/